4th Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$1,350,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

11 issue areas, each in the filer's own words, with who lobbied on it and where.

Torts TOR

- Issues related to civil justice reform.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
RILEY SWINEHART —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

- Patent Trade Office reforms - H.R.1520, "Purple Book Continuity Act of 2019", regarding all provisions - H.R.1503, "Orange Book Transparency Act of 2019", regarding all provisions - H.R.1499 "Protecting Consumer Access to Generic Drugs Act of 2019", regarding all provisions - S.659, "Biologic Patent Transparency Act", regarding all provisions. - S. 1419, "Early Participation in Regulations Act of 2019", regarding all provisions

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
ANNE BRUCE —
DAVID KAVANAUGH —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 659 (116th), H.R. 1520 (116th), S. 1419 (116th), H.R. 1499 (116th), H.R. 1503 (116th)

Labor Issues/Antitrust/Workplace LBR

- Issues related to corporate governance - Issues related to diversity & Inclusion

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LARRY CAMM New —
KELLY WATERS —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

-Issues related to the NAFTA/USMCA renegotiation issues. -Issues related to new tariff proclamations and retaliation.

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
DAVID KAVANAUGH —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

- Issues related to miscellaneous tax bills. - Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to replacing G1LT1 global average method with a per country minimum. - Issues related to CFC look through. - Issues related to the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 -"Restoring Access to Medication Act of 2019", regarding all provisions. - H.R. 2207/S. 693 "Protect Medical Innovation Act of 2019", regarding all provisions. - Issues related to the repeal of the medical device tax and the cadillac tax

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DARREL C JODREY —
DAVID KAVANAUGH —
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: S. 693 (116th), S. 780 (116th), S. 779 (116th), H.R. 1711 (116th), S. 1089 (116th), H.R. 1712 (116th), H.R. 1922 (116th), H.R. 2207 (116th)

Veterans VET

- Issues related to VA medical device procurement issues - Issues related to frontline health workers

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
ANNE BRUCE —
RILEY SWINEHART —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

- Issues related to reimbursement

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
ANNE BRUCE —
RILEY SWINEHART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Science/Technology SCI

- Issues related to data privacy. - Issues related to artificial intelligence.

LobbyistCovered position, as disclosed
LEIF BRIERLEY —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Health Issues HCR

- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: S. 2543 (116th), H.R. 863 (116th), S. 726 (116th), H.R. 19 (116th), H.R. 3 (116th)

Budget/Appropriations BUD

-Issues related to FY2020 Appropriations, specifically the Special Olympics, The Global Fund, Food & Drug Administration, Commerce, Interior, National Institutes of Health and Environmental Protection Agency budgets.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
DARREL C JODREY —
MEGHAN DRENAN STONE —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Environment/Superfund ENV

- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions - H.R. 2588/S. 1371 - Oxybenzone and Octinoxate Impact Study Act of 2019, regarding all provisions - H.R. 2587/S. 1375 - Reef Safe Act of 2019, regarding all provisions - Issues related to sterilization of medical devices - Issues regarding environmental sustainability

LobbyistCovered position, as disclosed
DARREL C JODREY —
MEGHAN DRENAN STONE —
RILEY SWINEHART —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 1834 (116th), H.R. 2588 (116th), H.R. 2587 (116th), S. 1371 (116th), S. 1375 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.